DeepScribe Analysis: $35M Raised
What is DeepScribe?
DeepScribe specializes in ambient AI technology that transforms patient conversations into clinical notes. Their unique approach leverages advanced speech recognition and context awareness to enhance documentation accuracy and efficiency. This innovation allows healthcare providers to focus more on patient care while reducing administrative burdens.
HQ Country
Berkeley, United States
Employees
51-200
Founded
2017
Industry
SaaS, HealthTech, AI/ML
Product Features & Capabilities
- AI Medical Scribe capturing clinical conversations
- AI Coding automating specialty-specific codes
- Customization Studio for personalized clinical notes
- DeepScribe Assist providing real-time insights
- AI Phone Agent automating patient calls.
How much DeepScribe raised
Series B - N/A
October 15, 2023Lead Investor: Not specified
Series A - $30 million
January 11, 2022Lead Investor: Index Ventures
Seed Round - $5.2 million
May 13, 2021Lead Investor: Bee Partners, Industry Ventures
Seed Round - N/A
September 1, 2019Lead Investor: Bee Partners
Pre-Seed Round - N/A
January 30, 2019Lead Investor: Not specified
Pre-Seed Round - N/A
July 1, 2017Lead Investor: Not specified
Financial Overview
$35MTotal Raised
Series B
October 15, 2023
Investors: Not specified
Series A$30 million
January 11, 2022
Investors: Index Ventures
Seed Round$5.2 million
May 13, 2021
Investors: Bee Partners, Industry Ventures
Seed Round
September 1, 2019
Investors: Bee Partners
Pre-Seed Round
January 30, 2019
Investors: Not specified
Pre-Seed Round
July 1, 2017
Investors: Not specified
